Document:

Prepared and filed by St Ives Financial

Exhibit 10.9.4

APPLERA CORPORATION/CELERA GENOMICS GROUP

1999 STOCK INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION   AGREEMENT

(Series FY02-6 Performance Units)

NON-QUALIFIED STOCK OPTION AGREEMENT dated as of April 19, 2002 by and between Applera Corporation, a Delaware corporation (the “Company”), and «Name», a regular salaried employee of the Company or one of its subsidiaries (“you”).

1.  Grant of Option.  The Company hereby grants to you an option (the “Option”) to purchase «Number» shares of its Celera Genomics Group Common Stock, par value $.01 per share (the “Celera Genomics Stock”), under the terms of the Applera Corporation/Celera Genomics Group 1999 Stock Incentive Plan (the “Plan”).

2.  Purchase Price of Option.  The purchase price of the shares of Celera Genomics Stock subject to the Option is $19.475 per share.

3.  Expiration Date of Option.  The Option will expire as of 12:00 a.m. midnight (New York time) on April 19, 2012 (the “Expiration Date”), unless it is terminated earlier as provided in this Agreement.

4.  Exercise.   The Option may be exercised in full on or after April 19, 2005, provided that, except as provided below, you are on the date of exercise, and have been at all times from the date of grant to the date of exercise, a regular employee of the Company or one of its subsidiaries.

5.  Termination of Employment.  If your employment with the Company or a subsidiary is terminated by you or the Company for any reason other than retirement, disability, or death, you may exercise the Option, to the extent that you would otherwise be entitled to do so at the date of termination of employment, at any time within 30 days after the date of termination, but not after the Expiration Date.

6.  Retirement or Disability.  If you retire under the terms of any qualified pension plan provided by the Company or one of its subsidiaries, or if you are totally and permanently disabled, the Option may be exercised as to the total number of shares subject to the Option (without regard to the exercise schedule set forth in paragraph 4) at any time within one year after the date of retirement or disability retirement, but not after the Expiration Date.

7.  Death.  If you die while employed by the Company or one of its subsidiaries, the Option may be exercised (to the extent that you would have been entitled to do so at the date of your death) by your executor or administrator (or other person at the time entitled by law to your rights under the Option) at any time within one year after the date of death, but not after the Expiration Date.

 

-1-

8.  Exercise of Option.  The Option may be exercised by giving written notice in the form specified by the Company to the Corporate Secretary at the principal office of the Company specifying the number of shares of Celera Genomics Stock to be purchased.  However, the Option may not be exercised as to fewer than 100 shares, or the remaining shares covered by the Option if fewer than 100, at any one time, and the Option may not be exercised with respect to a fractional share.  The purchase price of the shares as to which the Option is exercised must be paid in full at the time of exercise, at your election, (a) in U.S. currency, (b) by tendering to the Company shares of Celera Genomics Stock owned by you
for at least six months having a Fair Market Value (as defined in the Plan) equal to the aggregate purchase price of the shares as to which the Option is being exercised, (c) a combination of U.S. currency and/or previously owned shares of Celera Genomics Stock valued at Fair Market Value, or (d) by payment of such other consideration as the Management Resources Committee of the Board of Directors (the “Committee”) from time to time determines.  For purposes of this paragraph, Fair Market Value will be determined as of the business day immediately preceding the day on which the Option is exercised.

9.  Conditions to Exercise. The exercise of the Option within one year following termination of employment is subject to the satisfaction of the conditions that you have not (a) rendered services or engaged directly or indirectly in any business which in the opinion of the Committee competes with or is in conflict with the interests of the Company, or (b) violated any written agreement with the Company, including, without limitation, any confidentiality agreement.  Your violation of either clause (a) or (b) of the preceding sentence will result in the immediate forfeiture of any Options held by you.

10.  Tax Withholding Obligations.  As a condition to the delivery of shares of Celera Genomics Stock upon the exercise of the Option, you agree to pay to the Company an amount sufficient to satisfy any applicable tax withholding obligations.  Alternatively, you agree that the Company and your employer are expressly authorized to deduct the appropriate withholding taxes from your pay in order to satisfy any income, social, or other employment-related taxes related to your participation in the Plan.

11.  Rights as a Stockholder.  You will not have any rights as a stockholder with respect to the shares of Celera Genomics Stock subject to the Option prior to the issuance to you of a certificate for such shares.

12.  Transferability.  The Option may not be transferred other than by will or by the laws of descent and distribution, and the Option may be exercised, during your lifetime, only by you or your guardian or legal representative.

13.  Change of Control.  Subject to the terms of the Plan, the Option will become immediately exercisable in full (without regard to the exercise schedule set forth in paragraph 4) upon the occurrence of any of the events set forth in Section 11 of the Plan. 

 

-2-

14.  No Right to Continued Employment.  Neither the Option nor this Agreement confers upon you any right to continue to be an employee of the Company or any of its subsidiaries or interferes in any way with the right of the Company or any of its subsidiaries to terminate your employment at any time.  Except as provided in this Agreement, the Option will terminate upon the termination of your employment for any reason.  The Option will not be reinstated if you are subsequently reinstated as an employee of the Company or any subsidiary.

15.  No Right to Future Benefits.  The Plan and the benefits offered thereunder are provided by the Company on an entirely discretionary basis, and the Plan creates no vested rights in participants.  Neither the Option nor this Agreement confers upon you any benefit other than as specifically set forth in this Agreement and the Plan.  You understand and agree that the benefits offered under the Option and the Plan are not part of your salary and that receipt of the Option does not entitle you to any future benefits under the Plan or any other plan or program of the Company.

16.  Compliance with Law.   No shares of Celera Genomics Stock will be issued upon the exercise of the Option unless counsel for the Company is satisfied that such issuance will be in compliance with all applicable laws.

17.  Terms of Plan Govern.  This Agreement and the terms of the Option will be governed by the terms of the Plan which is hereby incorporated by reference in this Agreement.  In the event of any ambiguity in this Agreement or any inconsistency between the terms of this Agreement and the terms of the Plan, the terms of the Plan will govern.  By your signature below, you acknowledge receipt of the Prospectus for the Plan and agree to be bound by all of the terms of the Plan.

18.  Amendments.  The Option or the Plan may, subject to certain exceptions, be amended by the Committee at any time in any manner.  However, no amendment of the Option or the Plan will adversely affect in any material manner any of your rights under the Option without your consent.

19.  Governing Law.  This Agreement will be governed by and construed in accordance with the internal laws of the State of Delaware.

-3-

Back to Contents

IN WITNESS WHEREOF, this Agreement has been duly executed by the undersigned as of the day and year first written above. 

APPLERA CORPORATION

By:                      
               
               
               
               

        Chairman, President and

        Chief Executive Officer

Accepted and Agreed:

                    
               
               

«Name»

          

-4-

Back to Contents

APPLERA CORPORATION/CELERA GENOMICS GROUP

1999 STOCK INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION  AGREEMENT

(Series FY02-7 Performance Units)

NON-QUALIFIED STOCK OPTION AGREEMENT dated as of April 19, 2002 by and between Applera Corporation, a Delaware corporation (the “Company”), and «Name», a regular salaried employee of the Company or one of its subsidiaries (“you”).

1.  Grant of Option.  The Company hereby grants to you an option (the “Option”) to purchase «Number» shares of its Celera Genomics Group Common Stock, par value $.01 per share (the “Celera Genomics Stock”), under the terms of the Applera Corporation/Celera Genomics Group 1999 Stock Incentive Plan (the “Plan”).

2.  Purchase Price of Option.  The purchase price of the shares of Celera Genomics Stock subject to the Option is $19.475 per share.

3.  Expiration Date of Option.  The Option will expire as of 12:00 a.m. midnight (New York time) on April 19, 2012 (the “Expiration Date”), unless it is terminated earlier as provided in this Agreement.

4.  Exercise. The Option may be exercised in full on or after the earlier of (a) April 19, 2007 or (b) two years after all Stock Price Targets under the Series FY02-7 Performance Units granted to you on the date hereof have been attained, provided that, except as provided below, you are on the date of exercise, and have been at all times from the date of grant to the date of exercise, a regular employee of the Company or one of its subsidiaries.

5.  Termination of Employment.  If your employment with the Company or a subsidiary is terminated by you or the Company for any reason other than retirement, disability, or death, you may exercise the Option, to the extent that you would otherwise be entitled to do so at the date of termination of employment, at any time within 30 days after the date of termination, but not after the Expiration Date.

6.  Retirement or Disability.  If you retire under the terms of any qualified pension plan provided by the Company or one of its subsidiaries, or if you are totally and permanently disabled, the Option may be exercised as to the total number of shares subject to the Option (without regard to the exercise schedule set forth in paragraph 4) at any time within one year after the date of retirement or disability retirement, but not after the Expiration Date.

 

-1-

7.  Death.  If you die while employed by the Company or one of its subsidiaries, the Option may be exercised (to the extent that you would have been entitled to do so at the date of your death) by your executor or administrator (or other person at the time entitled by law to your rights under the Option) at any time within one year after the date of death, but not after the Expiration Date.

8.  Exercise of Option.  The Option may be exercised by giving written notice in the form specified by the Company to the Corporate Secretary at the principal office of the Company specifying the number of shares of Celera Genomics Stock to be purchased.  However, the Option may not be exercised as to fewer than 100 shares, or the remaining shares covered by the Option if fewer than 100, at any one time, and the Option may not be exercised with respect to a fractional share.  The purchase price of the shares as to which the Option is exercised must be paid in full at the time of exercise, at your election, (a) in U.S. currency, (b) by tendering to the Company shares of Celera Genomics Stock owned by you
for at least six months having a Fair Market Value (as defined in the Plan) equal to the aggregate purchase price of the shares as to which the Option is being exercised, (c) a combination of U.S. currency and/or previously owned shares of Celera Genomics Stock valued at Fair Market Value, or (d) by payment of such other consideration as the Management Resources Committee of the Board of Directors (the “Committee”) from time to time determines.  For purposes of this paragraph, Fair Market Value will be determined as of the business day immediately preceding the day on which the Option is exercised.

9.  Conditions to Exercise. The exercise of the Option within one year following termination of employment is subject to the satisfaction of the conditions that you have not (a) rendered services or engaged directly or indirectly in any business which in the opinion of the Committee competes with or is in conflict with the interests of the Company, or (b) violated any written agreement with the Company, including, without limitation, any confidentiality agreement.  Your violation of either clause (a) or (b) of the preceding sentence will result in the immediate forfeiture of any Options held by you.

10.  Tax Withholding Obligations.  As a condition to the delivery of shares of Celera Genomics Stock upon the exercise of the Option, you agree to pay to the Company an amount sufficient to satisfy any applicable tax withholding obligations.  Alternatively, you agree that the Company and your employer are expressly authorized to deduct the appropriate withholding taxes from your pay in order to satisfy any income, social, or other employment-related taxes related to your participation in the Plan.

11.  Rights as a Stockholder.  You will not have any rights as a stockholder with respect to the shares of Celera Genomics Stock subject to the Option prior to the issuance to you of a certificate for such shares.

12.  Transferability.  The Option may not be transferred other than by will or by the laws of descent and distribution, and the Option may be exercised, during your lifetime, only by you or your guardian or legal representative.

 

-2-

13.  Change of Control.  Subject to the terms of the Plan, the Option will become immediately exercisable in full (without regard to the exercise schedule set forth in paragraph 4) upon the occurrence of any of the events set forth in Section 11 of the Plan. 

14.  No Right to Continued Employment.  Neither the Option nor this Agreement confers upon you any right to continue to be an employee of the Company or any of its subsidiaries or interferes in any way with the right of the Company or any of its subsidiaries to terminate your employment at any time.  Except as provided in this Agreement, the Option will terminate upon the termination of your employment for any reason.  The Option will not be reinstated if you are subsequently reinstated as an employee of the Company or any subsidiary.

15.  No Right to Future Benefits.  The Plan and the benefits offered thereunder are provided by the Company on an entirely discretionary basis, and the Plan creates no vested rights in participants.  Neither the Option nor this Agreement confers upon you any benefit other than as specifically set forth in this Agreement and the Plan.  You understand and agree that the benefits offered under the Option and the Plan are not part of your salary and that receipt of the Option does not entitle you to any future benefits under the Plan or any other plan or program of the Company.

16.  Compliance with Law.   No shares of Celera Genomics Stock will be issued upon the exercise of the Option unless counsel for the Company is satisfied that such issuance will be in compliance with all applicable laws.

17.  Terms of Plan Govern.  This Agreement and the terms of the Option will be governed by the terms of the Plan which is hereby incorporated by reference in this Agreement.  In the event of any ambiguity in this Agreement or any inconsistency between the terms of this Agreement and the terms of the Plan, the terms of the Plan will govern.  By your signature below, you acknowledge receipt of the Prospectus for the Plan and agree to be bound by all of the terms of the Plan.

18.  Amendments.  The Option or the Plan may, subject to certain exceptions, be amended by the Committee at any time in any manner.  However, no amendment of the Option or the Plan will adversely affect in any material manner any of your rights under the Option without your consent.

19.  Governing Law.  This Agreement will be governed by and construed in accordance with the internal laws of the State of Delaware.

-3-

Back to Contents

IN WITNESS WHEREOF, this Agreement has been duly executed by the undersigned as of the day and year first written above. 

APPLERA CORPORATION

By:                      
               
               
               
               

        Chairman, President and

        Chief Executive Officer

Accepted and Agreed:

                    
               
               

«Name»

-4-

Back to Contents

APPLERA CORPORATION/CELERA GENOMICS GROUP

1999 STOCK INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION   AGREEMENT

(Series FY03-1 Performance Units)

NON-QUALIFIED STOCK OPTION AGREEMENT dated as of August 5, 2002 by and between Applera Corporation, a Delaware corporation (the “Company”), and «Name», a regular salaried employee of the Company or one of its subsidiaries (“you”).

1.  Grant of Option.  The Company hereby grants to you an option (the “Option”) to purchase «Number» shares of its Celera Genomics Group Common Stock, par value $.01 per share (the “Celera Genomics Stock”), under the terms of the Applera Corporation/Celera Genomics Group 1999 Stock Incentive Plan (the “Plan”).

2.  Purchase Price of Option.  The purchase price of the shares of Celera Genomics Stock subject to the Option is $9.675 per share.

3.  Expiration Date of Option.  The Option will expire as of 12:00 a.m. midnight (New York time) on August 5, 2012 (the “Expiration Date”), unless it is terminated earlier as provided in this Agreement.

4.  Exercise.   The Option may be exercised in full on or after August 5, 2005, provided that, except as provided below, you are on the date of exercise, and have been at all times from the date of grant to the date of exercise, a regular employee of the Company or one of its subsidiaries.

5.  Termination of Employment.  If your employment with the Company or a subsidiary is terminated by you or the Company for any reason other than retirement, disability, or death, you may exercise the Option, to the extent that you would otherwise be entitled to do so at the date of termination of employment, at any time within 30 days after the date of termination, but not after the Expiration Date.

6.  Retirement or Disability.  If you retire under the terms of any qualified pension plan provided by the Company or one of its subsidiaries, or if you are totally and permanently disabled, the Option may be exercised as to the total number of shares subject to the Option (without regard to the exercise schedule set forth in paragraph 4) at any time within one year after the date of retirement or disability retirement, but not after the Expiration Date.

7.  Death.  If you die while employed by the Company or one of its subsidiaries, the Option may be exercised (to the extent that you would have been entitled to do so at the date of your death) by your executor or administrator (or other person at the time entitled by law to your rights under the Option) at any time within one year after the date of death, but not after the Expiration Date.

 

-1-

8.  Exercise of Option.  The Option may be exercised by giving written notice in the form specified by the Company to the Corporate Secretary at the principal office of the Company specifying the number of shares of Celera Genomics Stock to be purchased.  However, the Option may not be exercised as to fewer than 100 shares, or the remaining shares covered by the Option if fewer than 100, at any one time, and the Option may not be exercised with respect to a fractional share.  The purchase price of the shares as to which the Option is exercised must be paid in full at the time of exercise, at your election, (a) in U.S. currency, (b) by tendering to the Company shares of Celera Genomics Stock owned by you
for at least six months having a Fair Market Value (as defined in the Plan) equal to the aggregate purchase price of the shares as to which the Option is being exercised, (c) a combination of U.S. currency and/or previously owned shares of Celera Genomics Stock valued at Fair Market Value, or (d) by payment of such other consideration as the Management Resources Committee of the Board of Directors (the “Committee”) from time to time determines.  For purposes of this paragraph, Fair Market Value will be determined as of the business day immediately preceding the day on which the Option is exercised.

9.  Conditions to Exercise. The exercise of the Option within one year following termination of employment is subject to the satisfaction of the conditions that you have not (a) rendered services or engaged directly or indirectly in any business which in the opinion of the Committee competes with or is in conflict with the interests of the Company, or (b) violated any written agreement with the Company, including, without limitation, any confidentiality agreement.  Your violation of either clause (a) or (b) of the preceding sentence will result in the immediate forfeiture of any Options held by you.

10.  Tax Withholding Obligations.  As a condition to the delivery of shares of Celera Genomics Stock upon the exercise of the Option, you agree to pay to the Company an amount sufficient to satisfy any applicable tax withholding obligations.  Alternatively, you agree that the Company and your employer are expressly authorized to deduct the appropriate withholding taxes from your pay in order to satisfy any income, social, or other employment-related taxes related to your participation in the Plan.

11.  Rights as a Stockholder.  You will not have any rights as a stockholder with respect to the shares of Celera Genomics Stock subject to the Option prior to the issuance to you of a certificate for such shares.

12.  Transferability.  The Option may not be transferred other than by will or by the laws of descent and distribution, and the Option may be exercised, during your lifetime, only by you or your guardian or legal representative.

13.  Change of Control.  Subject to the terms of the Plan, the Option will become immediately exercisable in full (without regard to the exercise schedule set forth in paragraph 4) upon the occurrence of any of the events set forth in Section 11 of the Plan. 

 

-2-

14.  No Right to Continued Employment.  Neither the Option nor this Agreement confers upon you any right to continue to be an employee of the Company or any of its subsidiaries or interferes in any way with the right of the Company or any of its subsidiaries to terminate your employment at any time.  Except as provided in this Agreement, the Option will terminate upon the termination of your employment for any reason.  The Option will not be reinstated if you are subsequently reinstated as an employee of the Company or any subsidiary.

15.  No Right to Future Benefits.  The Plan and the benefits offered thereunder are provided by the Company on an entirely discretionary basis, and the Plan creates no vested rights in participants.  Neither the Option nor this Agreement confers upon you any benefit other than as specifically set forth in this Agreement and the Plan.  You understand and agree that the benefits offered under the Option and the Plan are not part of your salary and that receipt of the Option does not entitle you to any future benefits under the Plan or any other plan or program of the Company.

16.  Compliance with Law.   No shares of Celera Genomics Stock will be issued upon the exercise of the Option unless counsel for the Company is satisfied that such issuance will be in compliance with all applicable laws.

17.  Terms of Plan Govern.  This Agreement and the terms of the Option will be governed by the terms of the Plan which is hereby incorporated by reference in this Agreement.  In the event of any ambiguity in this Agreement or any inconsistency between the terms of this Agreement and the terms of the Plan, the terms of the Plan will govern.  By your signature below, you acknowledge receipt of the Prospectus for the Plan and agree to be bound by all of the terms of the Plan.

18.  Amendments.  The Option or the Plan may, subject to certain exceptions, be amended by the Committee at any time in any manner.  However, no amendment of the Option or the Plan will adversely affect in any material manner any of your rights under the Option without your consent.

19.  Governing Law.  This Agreement will be governed by and construed in accordance with the internal laws of the State of Delaware.

-3-

Back to Contents

IN WITNESS WHEREOF, this Agreement has been duly executed by the undersigned as of the day and year first written above. 

APPLERA CORPORATION

By:                      
               
               
               
               

        Chairman, President and

        Chief Executive Officer

Accepted and Agreed:

                    
               
               

«Name»

-4-

Back to Contents

APPLERA CORPORATION/CELERA GENOMICS GROUP

1999 STOCK INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION   AGREEMENT

(Series FY03-2 Performance Units)

NON-QUALIFIED STOCK OPTION AGREEMENT dated as of August 5, 2002 by and between Applera Corporation, a Delaware corporation (the “Company”), and «Name», a regular salaried employee of the Company or one of its subsidiaries (“you”).

1.  Grant of Option.  The Company hereby grants to you an option (the “Option”) to purchase «Number» shares of its Celera Genomics Group Common Stock, par value $.01 per share (the “Celera Genomics Stock”), under the terms of the Applera Corporation/Celera Genomics Group 1999 Stock Incentive Plan (the “Plan”).

2.  Purchase Price of Option.  The purchase price of the shares of Celera Genomics Stock subject to the Option is $9.675 per share.

3.  Expiration Date of Option.  The Option will expire as of 12:00 a.m. midnight (New York time) on August 5, 2012 (the “Expiration Date”), unless it is terminated earlier as provided in this Agreement.

4.  Exercise. The Option may be exercised in full on or after the earlier of (a) August 5, 2007 or (b) two years after all Stock Price Targets under the Series FY03-2 Performance Units granted to you on the date hereof have been attained, provided that, except as provided below, you are on the date of exercise, and have been at all times from the date of grant to the date of exercise, a regular employee of the Company or one of its subsidiaries.

5.  Termination of Employment.  If your employment with the Company or a subsidiary is terminated by you or the Company for any reason other than retirement, disability, or death, you may exercise the Option, to the extent that you would otherwise be entitled to do so at the date of termination of employment, at any time within 30 days after the date of termination, but not after the Expiration Date.

6.  Retirement or Disability.  If you retire under the terms of any qualified pension plan provided by the Company or one of its subsidiaries, or if you are totally and permanently disabled, the Option may be exercised as to the total number of shares subject to the Option (without regard to the exercise schedule set forth in paragraph 4) at any time within one year after the date of retirement or disability retirement, but not after the Expiration Date.

 

-1-

7.  Death.  If you die while employed by the Company or one of its subsidiaries, the Option may be exercised (to the extent that you would have been entitled to do so at the date of your death) by your executor or administrator (or other person at the time entitled by law to your rights under the Option) at any time within one year after the date of death, but not after the Expiration Date.

8.  Exercise of Option.  The Option may be exercised by giving written notice in the form specified by the Company to the Corporate Secretary at the principal office of the Company specifying the number of shares of Celera Genomics Stock to be purchased.  However, the Option may not be exercised as to fewer than 100 shares, or the remaining shares covered by the Option if fewer than 100, at any one time, and the Option may not be exercised with respect to a fractional share.  The purchase price of the shares as to which the Option is exercised must be paid in full at the time of exercise, at your election, (a) in U.S. currency, (b) by tendering to the Company shares of Celera Genomics Stock owned by you
for at least six months having a Fair Market Value (as defined in the Plan) equal to the aggregate purchase price of the shares as to which the Option is being exercised, (c) a combination of U.S. currency and/or previously owned shares of Celera Genomics Stock valued at Fair Market Value, or (d) by payment of such other consideration as the Management Resources Committee of the Board of Directors (the “Committee”) from time to time determines.  For purposes of this paragraph, Fair Market Value will be determined as of the business day immediately preceding the day on which the Option is exercised.

9.  Conditions to Exercise. The exercise of the Option within one year following termination of employment is subject to the satisfaction of the conditions that you have not (a) rendered services or engaged directly or indirectly in any business which in the opinion of the Committee competes with or is in conflict with the interests of the Company, or (b) violated any written agreement with the Company, including, without limitation, any confidentiality agreement.  Your violation of either clause (a) or (b) of the preceding sentence will result in the immediate forfeiture of any Options held by you.

10.  Tax Withholding Obligations.  As a condition to the delivery of shares of Celera Genomics Stock upon the exercise of the Option, you agree to pay to the Company an amount sufficient to satisfy any applicable tax withholding obligations.  Alternatively, you agree that the Company and your employer are expressly authorized to deduct the appropriate withholding taxes from your pay in order to satisfy any income, social, or other employment-related taxes related to your participation in the Plan.

11.  Rights as a Stockholder.  You will not have any rights as a stockholder with respect to the shares of Celera Genomics Stock subject to the Option prior to the issuance to you of a certificate for such shares.

12.  Transferability.  The Option may not be transferred other than by will or by the laws of descent and distribution, and the Option may be exercised, during your lifetime, only by you or your guardian or legal representative.

 

-2-

13.  Change of Control.  Subject to the terms of the Plan, the Option will become immediately exercisable in full (without regard to the exercise schedule set forth in paragraph 4) upon the occurrence of any of the events set forth in Section 11 of the Plan. 

14.  No Right to Continued Employment.  Neither the Option nor this Agreement confers upon you any right to continue to be an employee of the Company or any of its subsidiaries or interferes in any way with the right of the Company or any of its subsidiaries to terminate your employment at any time.  Except as provided in this Agreement, the Option will terminate upon the termination of your employment for any reason.  The Option will not be reinstated if you are subsequently reinstated as an employee of the Company or any subsidiary.

15.  No Right to Future Benefits.  The Plan and the benefits offered thereunder are provided by the Company on an entirely discretionary basis, and the Plan creates no vested rights in participants.  Neither the Option nor this Agreement confers upon you any benefit other than as specifically set forth in this Agreement and the Plan.  You understand and agree that the benefits offered under the Option and the Plan are not part of your salary and that receipt of the Option does not entitle you to any future benefits under the Plan or any other plan or program of the Company.

16.  Compliance with Law.   No shares of Celera Genomics Stock will be issued upon the exercise of the Option unless counsel for the Company is satisfied that such issuance will be in compliance with all applicable laws.

17.  Terms of Plan Govern.  This Agreement and the terms of the Option will be governed by the terms of the Plan which is hereby incorporated by reference in this Agreement.  In the event of any ambiguity in this Agreement or any inconsistency between the terms of this Agreement and the terms of the Plan, the terms of the Plan will govern.  By your signature below, you acknowledge receipt of the Prospectus for the Plan and agree to be bound by all of the terms of the Plan.

18.  Amendments.  The Option or the Plan may, subject to certain exceptions, be amended by the Committee at any time in any manner.  However, no amendment of the Option or the Plan will adversely affect in any material manner any of your rights under the Option without your consent.

19.  Governing Law.  This Agreement will be governed by and construed in accordance with the internal laws of the State of Delaware.

-3-

IN WITNESS WHEREOF, this Agreement has been duly executed by the undersigned as of the day and year first written above. 

APPLERA CORPORATION

By:                      
               
               
               
               

        Chairman, President and

        Chief Executive Officer

Accepted and Agreed:

                    
               
               

«Name»

-4-Prepared and filed by St Ives Financial

Exhibit 10.9.5

APPLERA CORPORATION/CELERA GENOMICS GROUP 

1999 STOCK INCENTIVE PLAN 

FORM OF EMPLOYEE STOCK AWARD AGREEMENT 

EMPLOYEE STOCK AWARD AGREEMENT dated
  as of [Grant Date] by and between Applera Corporation, a Delaware corporation
  (the “Company”), and [Name], a regular salaried employee of the Company or one of its subsidiaries (“you”). 

1.    Grant
  of Employee Stock Award. The
  Company hereby grants to you an Employee Stock
  Award (the “Award”) for [Total Number of Shares] shares (the “Award
  Shares”) of its Celera Genomics Group Common Stock, par value $.01 per
  share (the “Celera Stock”), under the terms of the Applera Corporation/Celera
  Genomics Group 1999 Stock Incentive Plan (the “Plan”). 

2.   Vesting. The
        Award Shares will vest as to [One-Third of Total Number of Shares] Award
        Shares on [Last Day of First Fiscal Year Ending After the Grant Date],
        [One-Third of Total Number of Shares] Award Shares on [Last Day of Second
        Fiscal Year Ending After the Grant Date], and [One-Third of Total Number
        of Shares] Award Shares on [Last Day of Third Fiscal Year Ending After
        the Grant Date] (each a “Vesting Date”), provided that you
        have been at all times from the date of grant to and including the applicable
        Vesting Date [regular]1 an employee of the Company or one
        of its subsidiaries.2 

3.   Termination
          of Employment.  If
          your employment with the Company or a subsidiary is terminated by you
          or the Company for any reason prior to the vesting of all or a portion
          of the Award Shares, the Award Shares which have not vested will be
          forfeited and will revert back to the Company without payment to you
          of any consideration. 

4.   Delivery of Award Shares.  Certificates representing the Award Shares will be registered in your name but remain in the physical custody of the Company until the Award Shares have vested. In the event that all or a portion of the Award Shares are forfeited for any reason, those shares will revert back to the Company without payment to you of any consideration. 

5.   Payment
          of Dividends; Voting Rights. Prior
          to the vesting of the Award Shares, you will have the right to vote
          and to receive dividends, if any, on all of the unvested shares of
          Celera Stock covered by the Award. 

 

1 Applicable only to August 5, 2002, award grant. 

2 An
August 5, 2002, award grant to Robert F.G. Booth vested in three installments,
25% on each of the first and second anniversaries of the grant date and 50% on
the third anniversary of the grant date. An August 21, 2003, award grant
to Tony L. White is subject to the vesting schedule set forth in this Section
2. 

6.   Non-Transferability. Prior
      to the time that shares of Celera Stock issued pursuant to the Award are
      delivered to you, none of such shares may be sold, assigned, bequeathed,
      transferred, pledged, hypothecated, or otherwise disposed of in any way.
    

7.   Change
          of Control. Subject
          to the terms of the Plan, all Award Shares will be deemed vested (without
          regard to the Vesting Dates) upon the occurrence of any of the events
          set forth in Section 11 of the Plan.

8.   No
          Right to Continued Employment. Neither
          the Award nor this Agreement confers upon you any right to continue
          to be an employee of the Company or any of its subsidiaries or interferes
          in any way with the right of the Company or any of its subsidiaries
          to terminate your employment at any time. The Award will terminate
          upon the termination of your employment for any reason. The Award will
          not be reinstated if you are subsequently reinstated as an employee
          of the Company or any subsidiary. 

9.   No
          Right to Future Benefits. The
          Plan and the benefits offered under the Plan are provided by the Company
          on an entirely discretionary basis, and the Plan creates no vested
          rights in participants. Neither the Award nor this Agreement confers
          upon you any benefit other than as specifically set forth in this Agreement
          and the Plan. You understand and agree that the benefits offered under
          the Award and the Plan are not part of your salary and that receipt
          of the Award does not entitle you to any future benefits under the
          Plan or any other plan or program of the Company. 

10.   Compliance
          with Law. No
          shares of Celera Stock will be delivered to you upon the vesting of
          the Award Shares unless counsel for the Company is satisfied that such
          delivery will be in compliance with all applicable laws. 

11.   Entire
          Agreement.  This
          Agreement and the Plan contain the entire agreement between you and
          the Company regarding the Award and supersede all prior arrangements
          or understandings with respect thereto. 

12.   Terms
          of Plan Govern. This
          Agreement and the terms of the Award will be governed by the terms
          of the Plan which is hereby incorporated by reference in this Agreement.
          In the event of any ambiguity in this Agreement or any inconsistency
          between the terms of this Agreement and the terms of the Plan, the
          terms of the Plan will govern. By your signature below, you acknowledge
          receipt of the Plan Summary and agree to be bound by all of the terms
          of the Plan. 

13.   Amendments. The
      Award or the Plan may, subject to certain exceptions, be amended by the
      Committee at any time in any manner. However, no amendment of the Award
      or the Plan will adversely affect in any material manner any of your rights
      under the Award without your consent.

14.   Governing
          Law. This
          Agreement will be governed by and construed in accordance with the
          internal laws of the State of Delaware. 

2

  IN WITNESS WHEREOF, this Agreement has been duly executed by the undersigned as of the day and year first written above.

	 	 	APPLERA
    CORPORATION 
	 	 	 	 
	 	 	 	 
	 	 	By: 	

	 	 	 	 
	Accepted
    and Agreed: 	 	 	 
	 	 	 	 
	 	 	 	 
	
	 	 	 
	 [Name] 	 	 	 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]